Telomerase is a promising target for human cancer gene therapy. Its inhibition allows telomere shortening to occur in cancer cells, which in turn is thought to trigger delayed senescence and / or apoptosis. We tested whether telomerase inhibition might have additional, immediate effects on tumor cell growth. Ovarian cancer cell lines with widely differing telomere lengths were efficiently transduced with an adenovirus expressing a ribozyme directed against the T motif of the catalytic subunit of human telomerase, hTERT. Three days after transduction, telomerase activity was significantly reduced and massive cell loss was induced in mass cultures from all four ovarian cancer cell lines tested, whereas transduction of telomerase -negative human fibroblasts did not attenuate their growth. The kinetics of induction of cell death in cancer cells was not significantly dependent on telomere length, and telomeres did not shorten measurably before the onset of apoptosis. The data suggest the existence of a ''fast -track'' mechanism by which diminution of telomerase can interfere with cancer cell growth and induce cell death, presumably by apoptosis. This phenomenon might be a consequence of the telomere capping function provided by telomerase in tumor cells. Uncapping of telomeres by ribozyme -mediated inhibition of telomerase bears therapeutic potential for ovarian cancer.
F
or transient high -level expression of toxic gene products, as required in cancer treatment, adenoviruses are an efficient tool 1,2 employed in many clinical trials. For ovarian cancer, a disease with early intraperitoneal spread and poor prognosis, several adenovirus type 5 -based approaches of intraperitoneal gene therapy are currently under investigation in clinical trials. The target of this strategy is the remainder of intraperitoneally disseminated cancer cells after cytoreductive surgery. Recently, we reported results of a phase I /II and a phase II / III trial using p53 as a therapeutic gene. 3 Telomeres are specialised DNA -protein structures that define the ends of all linear chromosomes. In human somatic cells, they shorten with each cell division due to the inability of conventional polymerases to replicate the very end of linear DNA 4, 5 as well as due to the lower efficiency of single -strand break repair in telomeres. 6 -8 Eventually, telomere shortening triggers the activation of DNA damage pathways leading to cell -cycle arrest, senescence or apoptosis 9, 10 via mechanisms that are still unknown. In immortal cell lineages, telomere shortening is compensated for by the unique reverse transcriptase: telomerase. Expression of telomerase in human cells is tightly connected to the cancer phenotype, 11 which makes this enzyme a highly specific target for anticancer treatments and the development of new antineoplastic drugs.
Different successful approaches to telomerase inhibition in tumor cells have been reported. 12 -19 In many of these experiments it was shown that telomerase inhibition had to be maintained for a long time to result in the death of a culture. Telomere shortening preceding cell death 12, 19 and / or a positive correlation between the initial telomere length and the time span until death 15 -17 was demonstrated. In extreme cases a delay of several months was observed 16 and cells with very long telomeres could not be driven into apoptosis at all. 17 However, in some studies a very fast apoptotic response ( within few days ) to inhibition of telomerase was reported, which was apparently not dependent on telomere shortening. 13, 14, 19 We recently described a ribozyme approach against the T motif of the catalytic subunit of human telomerase, hTERT. 19 By observing single clones expressing the ribozyme we also found a significant lag phase before cell death, which was characterised by telomere shortening and concomitant slowing of net cellular growth. However, when mass cultures of the same cells were adenovirally transduced to express the same ribozyme, most of the cells died by apoptosis within a few days, before any telomere shortening could be measured. 19 These data suggested two different mechanisms by which inhibition of telomerase could lead to net growth arrest or apoptosis in cancer cells: one being a ''fast -track,'' not requiring telomere shortening possibly due to interfer-ence with the ''capping'' function of telomerase, 20 and the other one being the ''classical'' mechanism induced by slow telomere shortening in those cells that were able to survive the ''fast -track'' mechanism.
To test this possibility of rapid apoptosis induction in ovarian cancer cells, we examined the response of mass cultures of ovarian tumor cells with widely different telomere lengths to an efficient expression of the antitelomerase ribozyme by adenoviral transduction. Telomerase activity was significantly diminished in all mass cultures of ovarian cancer cells between 2 and 7 days after viral transduction. Massive cell death was induced without delay in cancer cells with both short and long telomeres without preceding telomere shortening. Thus, this study confirms that inhibition of telomerase compromises cancer cell growth and survival immediately.
MATERIALS AND METHODS

Cell culture and adenoviral transduction
Ovarian cancer cell lines OV-2774 and OVCAR -3 were obtained from ATCC. The lines OV-MZ -2A and OV-MZ -38 were previously established. 21 The primary human fibroblast line F -13 was established at the Institute of Pathology (Charite Berlin, Germany ). The cells were grown in DMEM plus 10% fetal calf serum in a humidified atmosphere of air plus 5% CO 2 at 378C.
The recombinant adenovirus AdLacZ, which expressed the bacterial -galactosidase gene under control of the CMV promoter was used to determine the transduction efficiency for each cell line. 22 The following virus titers resulted in the staining of 60% to > 90% of the cells after 24 hours: OV-2774: 40 pfu, OV-MZ-38: 20 pfu, OV-MZ -2A: 20 pfu, OVCAR -3: 10 pfu. These titers were used for transduction of cells with the ribozyme -carrying adenovirus (AdR4 ) as well as with AdLacZ for control. For viral transduction, cells were plated at a density of 10 4 cells / cm 2 . Viral transduction was performed on the following day in a minimal volume of serum -free DMEM for 1 hour. Mock -treated (i.e., without virus ) cultures were used as additional controls.
Ribozyme and adenovirus construction
The hammerhead ribozyme (R4 ) was designed to cleave the hTERT mRNA within the T motif, 3 0 of the C at the position 1744 (Gene Bank No. AF015950). Its sequence is 5 0 -UCUCCGU CUGAUGAGUCCGUGAGGACGAA ACA-UAAAAG -3 0 . The recombinant adenovirus expressing the ribozyme was constructed as described. 19 Briefly, the ribozyme was cloned between the EcoRI and BamHI sites of the pCDNA3.1 vector (Invitrogen, Carlsbad, CA ). A 977-bp SalI -PCR fragment of pCDNA3.1( R4 ) comprising the R4 expression cassette was inserted into the SalI site of the viral shuttle plasmid pHVad2, which carries an E1 deletion. The plasmid for rescue of the AdR4 virus was generated by homologous recombination in E. coli BJ5183 after cotransformation of a PacI/BstEII fragment of pHVad2 -R4 with the meganuclease-linearized vector pHVad1, an E3 -deleted viral backbone. The plasmid was amplified by transformation into E. coli HB101, and virus rescue and preparation was performed in 293 cells. 19 The total number of viral particles was determined spectrophotometrically, and infectious units ( pfu ) were determined by plaque assays on 293 cells. For control, an adenovirus ( AdLacZ ) expressing the bacterial -galactosidase under control of the CMV promoter was used. 22 Characterization of treated cells hTERT mRNA abundance was measured by RT-PCR. Total RNA was isolated using RNAclean ( Quiagen, Holden, Germany ) and cleaned with 0.5 U / l DNAseI (Boehringer, Mannheim, Germany ). One microgram RNA was reverse transcripted by MMLV transcriptase ( GIBCO ) using random primers ( Promega, Madison, WI ). cDNA corresponding to 50 ng RNA was used in a PCR reaction with the primers 558Â6 ( located in hTERT exon 6 ): GTC ATC GCC AGC ATC ATC and 749Â8 (located in exon 8): GTT CTC CAT GTC GCC GTAG. PCR conditions were 948C 30 seconds, 608C 30 seconds, 728C 30 seconds, 35 cycles. A GAPDH fragment of 474 bp was amplified as loading control using the primers fw5: TTC GAC AGT CAG CCG CAT CTT CTT, rev5: TCT CAT GGT TCA CAC CCA TGA CGA ACA TG at the following PCR conditions: 948C 30 seconds, 578C 30 seconds, 728C 30 seconds, 28 cycles. In preliminary experiments the cycle numbers were adjusted to remain below the saturation level of amplification. Experiments were performed in triplicate.
Telomerase assays utilized the semiquantitative TRAP Assay ( Intergen, Purchase, NY ). Lysates equivalent to 2000 cells were analyzed in a telomerase reaction for 30 minutes followed by 27 PCR cycles (30 seconds 958C, 45 seconds 598C ). Gels were scanned in a phosphorimager ( Molecular Dynamics, Sunnyvale, CA ). To estimate telomerase activities, the characteristic signal intensities were related to those of the PCR amplification standard TSK1 and of the quantification standard R8. The data were expressed as ''total product generated'' values according to the recommendations of the manufacturer.
Telomere length was measured as described. 6, 7 Briefly, DNA was embedded in agarose plugs, and plugs were digested with proteinase K. HinfI -restricted DNA was run in a 1% agarose gel in a CHEFIII pulsed field gel apparatus ( Bio -Rad, Hercules, CA ) for 15 hours at 3 V / cm. After Southern blotting, hybridization was done with an 18 -mer telomeric probe directly coupled to alkaline phosphatase ( Promega, Madison, WI ).
The percentage of apoptotic cells was estimated by flow cytometry (PAS, Partec, Münster, Germany ). The small, granular apoptotic cells were discriminated from viable cells by their lower forward and higher sideward light scatter. 23 Both adherent and nonadherent cells were collected, stained for 15 minutes with 10 g /mL propidium iodide (PI ) to determine the fraction of cells with damaged plasma membranes, and forward /sideward scattergrams were taken using blue light excitation in the flow cytometer. Gates were defined in the forward / sideward scattergrams to include either the normal or the apoptotic cells, and the fraction of apoptotic cells was estimated as cell counts in the apoptotic gate divided by the sum of counts in both gates. PI-positive cells were counted separately after appropriate gating.
Preliminary experiments confirmed that the quantification of forward /sideward scattergrams, the estimations of sub -G1 cells in flow cytometry and the counting of TUNEL -positive cells all gave comparable results for both breast and ovarian tumor cells ( Ref. 19 and data not shown). Adherent cells were counted daily in parallel wells in a hemocytometer. To characterize the population dynamics, net population doublings (NPDs ) were calculated as NPD = log 2 (n x /n 0 ) with n x and n 0 being the cell numbers at times x and 0, respectively. Net growth rates were estimated as the slope of the linear regression between NPD values and time for the first 7 days following transduction. In diminishing populations with a negative net growth rate, the culture half -life time is the inverse of the absolute value of the net growth rate.
RESULTS
AdR4 transduction diminishes telomerase activity and attenuates hTERT mRNA levels
A ribozyme was designed to cleave the hTERT mRNA within the T motif, 3
0 of the C at the position 1744 (Gene Bank No. AF015950 ). This ribozyme was cloned into the adenovirus AdR4. 19 The human ovarian cancer cell lines OVCAR -3, OV-MZ -38, OV-2774, and OV-MZ -2A were transduced with either the control virus AdLacZ expressing the LacZ gene or with AdR4. We had shown before that AdR4 transduction leads to ribozyme expression, attenuation of hTERT mRNA levels and diminution of telomerase activity in breast tumor cells. 19 In ovarian cancer cells, AdR4 also diminished hTERT mRNA steady -state levels and telomerase activity significantly two days after transduction, and both parameters remained low for up to 7 days ( Fig 1   Figure 1 . AdR4 transduction attenuates hTERT mRNA abundance in OVCAR -3 ovarian cancer cells. RT -PCR of OVCAR -3 mRNA at the indicated time points ( in days ) after transduction with either AdLacZ ( L ) or AdR4 ( R4 ). GAPDH was used as control. The chosen primers reveal the two major splice variants of hTERT. and data not shown ). With similar kinetics, telomerase activity was significantly reduced in all four cell lines ( Fig  2 ) . Semiquantitative evaluation of telomerase activity resulted in the activities as indicated in Table 1 . A significant diminution of telomerase activity to about 25% or less of the activity in control virus -transduced cells was obtained in mass cultures from all cell lines.
AdR4 transduction induces massive apoptosis and reverses cell net growth immediately
The fraction of apoptotic cells in control and AdR4 -treated ovarian cancer cell cultures was measured for 1 week after transduction by flow cytometry. Apoptotic cells were discriminated by their lower intensity in the forward lightscatter channel ( FSC ) and higher intensity in the sideward light-scatter channel (SSC ), reflecting their smaller size and higher granularity (Fig 3) . No functional assays of apoptosis were performed; however, the equivalence of this flow cytometric estimation with results from both TUNEL staining and enumeration of sub -G1 cells had been established in preliminary experiments. Although the fraction of apoptotic cells remained essentially constant after AdLacZ transduction, we found that most cells shifted from the normal to the apoptotic compartment within a few days after transduction with AdR4. The integrity of the plasma membrane was tested by PI exclusion. Less than 2% of the cells in the high FSC /low SSC compartment were Activities are expressed as total product generated values ( in percent of the activity in AdLacZ -transduced cells, see Materials and methods ) and are given as mean ± SEM of at least two independent experiments. stained with PI, confirming the cells in this compartment as being viable. However, between 10% and 60% of the cells in the low -FSC /high -SSC ( apoptotic ) compartment were positive for PI, with a clear tendency to find more PIpositive cells at later stages ( Fig 3 ) . Many of these cells, which lost the dye exclusion ability, are probably late -phase apoptotic.
Quantitative evaluation of the scattergrams revealed that AdLacZ transduction increased the background level of apoptotic cells ( Fig 4) . This was most evident in OV-2774 cells. However, even in this case no more than 20% of the cells were in the apoptotic compartment 1 week post transduction with the LacZ virus. However, the fractions of apoptotic cells rose steeply in all AdR4 -transduced cultures. Starting from control levels at day 1 post transduction, they reached values between 70% and 95% within 1 week ( Fig  4 ) . The rate of apoptosis induction appeared to be lowest in OV-MZ-2A cells.
The induction of cell death was reflected by a steep decrease in cell numbers (Fig 5 ) . Net cellular growth rates were estimated by counting of adherent cells in parallel dishes between days 0 and 7 after transduction followed by calculation of the regression between NPD and time. Transduction with AdLacZ decreased proliferation, the decrease being significant in OV-MZ -2A cells. However, AdR4 transduction induced massive apoptosis, which completely outweighed cell growth in all cancer cell lines, resulting in a limited half -life of all populations. Half-life times ( mean ± SEM, in days ) were estimated as the average from three independent experiments each as OV-2774: The kinetics of apoptosis induction and growth reduction were slightly different between cell lines. The increase in the fraction of apoptotic cells was slowest in the line OV-MZ -2A ( Fig 4 ) , whereas this line displayed a fast loss of adherent cells (Fig 5 ) . In OVCAR -3, about 80% of the cells were found in the apoptotic compartment 3 days after AdR4 transduction, but this cell line was the one with the longest half -life time. Whether these differences are due to a limited specificity of the flow cytometric method used for the detection of apoptosis, to different turnover rates of apoptotic cells, or to other reasons is unclear. Population half -life times appeared to be a more robust parameter to describe the net effect of the treatments on cell survival.
To test whether the induction of cell death in ovarian cancer cells was simply due to a nonspecific cytotoxicity of the AdR4 virus, we transduced human primary fibroblasts, which did not express hTERT, with either AdLacZ or AdR4. Their net growth rates were measured as well ( Fig 5 ) . Transduction with the AdLacZ virus attenuated cell proliferation to a similar amount as it did in cancer cells. In contrast to the telomerase -positive tumor cell lines, however, the effect of AdR4 transduction on fibroblast proliferation was indistinguishable from the AdLacZ virus. Transduction of the anti -hTERT ribozyme induced a limited half -life time in all four tested ovarian cancer mass cell cultures, but not in a telomerase-negative fibroblast culture, confirming that the growth -inhibitory effect of AdR4 transduction was dependent on the inhibition of telomerase.
Induction of cell death by AdR4 transduction is not accompanied by telomere shortening
It has been suggested repeatedly that the antiproliferative effect of telomerase inhibition would be mediated by shortening of telomeres. 12, 16, 17 We found strong induction of cell death already within 2 -4 days after AdR4 transduction in four ovarian cancer cell lines (Fig 4 ) . To find out whether measurable telomere shortening occurred concomitant to apoptosis induction, we compared telomere lengths 3 days after AdR4 transduction to that in uninfected and AdLacZ -transduced cells (Fig 6 ) . Telomere lengths varied significantly between the four cancer cell lines: OV-MZ -38 had very long telomeres with an average length of 10 to 20 kb. Telomeres in OVCAR -3 were also long with an average length of 10 kb, whereas those in OV-MZ -2A and OV-2774 were significantly shorter with an average length of about 5 kb. Thus, the two ovarian cancer cell cultures with shorter half -life times after AdR4 transduction were also the ones with shorter telomeres. However, the correlation between half -lives of the four examined cell cultures after AdR4 transduction and telomere lengths was not statistically significant.
Shortening of telomeres following AdR4 transduction was not observed ( Fig 6 ) . The telomeric signals in AdR4 -transduced OVCAR -3 and OV-2774 cultures were weaker due to lower numbers of cells available for analysis. Scanning of the telomeric signals revealed that neither the average telomere length nor the relative abundance of the shortest telomeres was changed after adenovirus treatment ( data not shown ). These results confirm that there is no measurable shift in the telomere length distribution within 3 days after inhibition of telomerase in the examined cell lines, i.e., at a time point when massive cell death is induced.
DISCUSSION
Our data demonstrate that the expression of a ribozyme cleaving the hTERT mRNA within the T motif inhibited telomerase and induced massive cell death in ovarian cancer cells. This occurred within a time frame of only 3 days, without measurable telomere shortening. This result is in accordance with data obtained by others using a 2-5A antisensense directed against hTR 13, 14 as well as with observations of AdR4 -transduced HBL -100 cells. 19 However, in a number of other studies, significant cell loss was observed only following prolonged telomerase inhibition, typically for many weeks. 12,15 -18 In these studies, cell loss after telomerase inhibition appeared to be dependent on telomere length. It is interesting to note that in some of the studies that suggested the necessity of telomere shortening for cell loss a functional inhibition was performed by overexpression of a dominant -negative telomerase mutant, which lost its catalytic activity but still retained its DNA binding capacity. 15, 17 Such a mutant might still be able to protect the telomeric end by capping. Importantly, many studies relied on observations in selected cell clones. 12,16 -18 For instance, we found an immediate induction of apoptosis by the anti -hTERT ribozyme in HBL -100 cells following viral transduction. If the same cells were stably transfected by electroporation, we obtained few clones that could be expanded. In these clones, we observed telomere loss and, eventually, net growth arrest. 19 The most obvious explanation for these results would be that inhibition of telomerase expression induces cell death, most probably by apoptosis in cancer cells directly. It was suggested that telomerase could be one means to cap and protect telomeres from signalling into cell -cycle arrest/ apoptosis pathways, and that its loss would uncap the telomeric ends, thereby triggering an arrest and/ or apoptosis signal. It was further suggested that the probability of triggering such a signal would be a stochastic function of telomere length. 20 These suggestions are well in accordance with recent data on telomere structure and function, which show that the very end of the telomere, a G -rich singlestranded overhang of the 3 0 end, is normally well protected by intercalation into the telomeric double strand, thus forming a loop structure, which is stabilised by certain telomeric proteins. 24 An unprotected G -rich telomeric single strand is a strong inducer of p53 and its downstream effectors, 25 and a free single -stranded telomeric end might also trigger apoptosis. 10 Telomerase, if present and functional, binds to the G -rich single -stranded telomeric end. Presumably, this binding protects the end and prohibits a signal to emanate from it. So, telomerase might stabilise cell growth directly by binding to telomeres. Dominant -negative telomerase mutants might still retain at least some capping ability.
Our data support a direct relevance of telomerase for protection against cell death and apoptosis. Inhibition of telomerase in mass cultures of ovarian cancer cells induced massive cell death within 3 days, before any measurable telomere shortening took place. Rapid induction of cell death by adenovirally transferred and ribozyme -mediated telomerase inhibition was also noted in tumor lines with long telomeres. This offers an attractive strategy for antitumor gene -based therapy.
